China Universal Asset Management Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 18,554 shares of RARE stock, worth $512,275. This represents 0.06% of its overall portfolio holdings.
Number of Shares
18,554
Previous 19,580
5.24%
Holding current value
$512,275
Previous $823,000
18.47%
% of portfolio
0.06%
Previous 0.08%
Shares
16 transactions
Others Institutions Holding RARE
# of Institutions
335Shares Held
89.4MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$276 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$155 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$115 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$88.9 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$72.3 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.93B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...